Categories: News

Delota Corp. Announces Grant of Options And RSUs

Vaughan, Ontario–(Newsfile Corp. – July 11, 2023) – Delota Corp. (CSE: LOTA) (“Delota” or the “Company“) an established Canadian vape and cannabis retailer, is pleased to announce the grant of stock options (each an “Option“) and restricted share units (each an “RSU“) pursuant to the Company’s omnibus plan (the “Plan“).

The Company has granted an aggregate of 1,710,000 Options and an aggregate of 640,000 RSUs to certain directors, officers, employees, and consultants of the Company. Each Option is exercisable at a price of $0.11 per common share, expires four years from the date of grant and vests immediately. Each Option is exercisable to purchase one common share in the capital of the Company. Each RSU granted vests immediately. All of the Options and RSUs (and any common shares issuable upon exercise thereof) will be subject to a four month and one day hold period pursuant to the polices of the Canadian Securities Exchange and applicable securities laws.

About Delota Corp.

Delota is an established vape and cannabis retailer that curates and sells vape and nicotine-related products, other smoking cessation products, cannabis products, and accessories where regulations permit. The Company currently operates 28 brick-and-mortar specialty vape stores in Ontario under the 180 Smoke Vape Store banner name, a leading Canada-wide specialty vape e-commerce platform (www.180smoke.ca), and five licensed dispensaries under the Offside Cannabis banner name in Ontario.

For further information, please contact:

Delota Corp.

Cameron Wickham
Executive Vice Chair and CEO
T: (905) 330-1602
E: info@delota.com

Neither the Canadian Securities Exchange nor its Regulation Services Provider have reviewed or accept responsibility for the adequacy or accuracy of this release.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/173066

Staff

Recent Posts

Vent Creativity Appoints Paul Abrams as Vice President of Sales to Lead Commercial Growth

NEW YORK--(BUSINESS WIRE)--Vent Creativity, a medical technology company advancing AI-enabled surgical planning, today announced the…

14 hours ago

AEON Clinic Announces Next Generation Medicine Congress 2026 Event: A Global Convergence on Human Longevity in Dubai

AEON Clinic Elevates Dubai to Global Hub for Longevity Science, A Definitive Four-Day Summit Defining…

14 hours ago

AI-Era Position Statement to Protect the Integrity of Healthcare, Technology, and Services Benchmarking published by Black Book Research

Black Book outlines an AI-era integrity architecture for healthcare benchmarking, instrumentation hardening, tiered verification, real-time…

2 days ago

New employee representative on the Board of Directors of Novo Nordisk A/S

Bagsværd, Denmark, 31 January 2026 – Thomas Rantzau, employee representative on the Board of Directors since…

2 days ago

Embers to Empowerment: The Womb Room Reopens in Govans, Expanding Community-Centered Perinatal Care After Hampden Fire

Baltimore, Maryland, Jan. 31, 2026 (GLOBE NEWSWIRE) -- After sustaining water damage during the massive…

2 days ago

Oxford Healthspan to Introduce New Primeadine® GF Powder Through a ‘Longevity Shot’ Experience During Grammy Week in Los Angeles

Science-Backed Spermidine Ritual Brings Cellular Renewal to a High-Performance Cultural Moment Primeadine Longevity Shot Primeadine…

2 days ago